Gubra is a biotech company delivering pre-clinical contract research services within obesity and diabetes. We combine cutting-edge technology, our accumulated experience and proven methodology to challenge current beliefs.

Watch our newest film to learn more about how our approach to CNS stereology can make a difference in your study.

Gubra is currently setting up an unique diet-induced NAFLD/NASH mouse model. The model includes pre-study biopsies for assessment and stratification of individual disease progression before evaluating the potential of your compound. Read more here.

Gubra is hiring. See our open positions here.